Biological and molecular analysis of a low-grade recurrence of a glioblastoma multiforme

Clinical Cancer Research

Volumn 2, Issue 1, 1996, Pages 187-199

  Scheck, Adrienne C ^a,b   Shapiro, Joan Rankin ^a   Coons, Stephen W ^b   Norman, Sylvia A ^a   Johnson, Peter C ^b  

^a ST JOSEPH'S HOSPITAL AND MEDICAL CENTER   (United States)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER RECURRENCE; CASE REPORT; CYTOGENETICS; FEMALE; FLOW CYTOMETRY; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; PRIORITY JOURNAL;

ADULT; CELL DIVISION; CHROMOSOME ABERRATIONS; FEMALE; FLOW CYTOMETRY; GENES, DCC; GLIOBLASTOMA; HUMANS; KI-67 ANTIGEN; NEOPLASM RECURRENCE, LOCAL; PLOIDIES; PROTEIN-TYROSINE-PHOSPHATASE; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 0030031866     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (85)

1. Loeb, L. Microsatellite instability: marker of a mulator phenotype in cancer. Cancer Res., 54: 5059-5063, 1994.
2. Horii, A, Han, H. J., Shimada, M., Yanagisawa, A., Kato, Y., Ohta, H., Yasui, W., Tahara, E., and Nakamura, Y. Frequent replication errors at microsatellite loci in tumors of patients with multiple primary cancers. Cancer Res., 54, 3373-3375, 1994.
3. Manuelidis, L. Genomiu stability and instability in different neuroepithelial tumors. A role for chromosome structure? J Neuro. Oncol., 18: 225-239, 1994.
4. Tofilon, P. J., Wheeler, K. T., and Deen, D. F. Detection of heterogeneity in the chemosensitivity of 9L brain tumor cell lines to 1,3-bis(2-chloroethyl)-1-nitrosourea by the sister chromatid exchange assay. Eur. J. Cancer Oncol., 20: 927-931, 1984.
5. Yaes, R. J. Tumor heterogeneity, tumor size, and radioresistance. Int. J. Radiat. Oncol. Biol. Phys., 17: 993-1005, 1989
6. Bigner, D. D., Bigner, S. H., Pontén, J., Westermark, B., Mahaley, M. S., Ruoslahti, E., Hirschman, H., Eng, L. F., and Wikstrand, C. J. Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J. Neuropathol. Exp. Neurol., 40: 201-229, 1981.
7. Hoshino, T. Heterogeneity of tumor cell DNA content. Prog. Exp. Tumor Res, 27: 83-91, 1984.
8. Heppner, G. H. Tumor heterogeneity. Cancer Res., 44: 2259-2265, 1984.
9. Shapiro, J. R., Mehta, B. M., Ebrahim, S. A. D., Scheck, A. C., Moots, P. L., and Fiola, M. R. Tumor heterogeneity and intrinsically chemoresistant subpopulations in freshly resected human malignant gliomas. In: O. Sudilovsky, H. C. Pitot, and L. A. Liotta (eds.), Boundaries between Promotion and Progression during Carcinogenesis, pp. 243-262. New York: Plenum Press, 1991.
10. Strommer, K., Hamou, M. F., Diggelmann, H., and De Tribolet, N. Cellular and tumoural heterogeneity of EGFR gene amplification in human malignant gliomas. Acta Neurochir., 107: 82-87, 1990.
11. Coons, S. W., and Johnson, P. C. Regional heterogeneity in the proliferative activity of human gliomas as measured by the Ki-67 labeling index. J. Neuropathol. Exp. Neurol., 42: 609-618, 1993.
12. Yang, X., Darling, J. L., McMillan, T. J., Peacock, J. H., and Steel, G. G. Heterogeneity of radiosensitivity in a human glioma cell line. Int. J. Radiat. Oncol. Biol. Phys., 22: 103-108, 1992.
13. Coons, S. W., and Johnson, P C. Regional heterogeneity in the DNA content of human gliomas. Cancer (Phila.), 72: 3052-3060, 1993.
14. Coons, S. W., Johnson, P. C., and Shapiro, J. R. Cytogenetic and flow cytometry DNA analysis of regional heterogeneity in a low-grade glioma. Cancer Res., 55: 1569-1577, 1995.
15. Shapiro, J. R., Yung, W. A., and Shapiro, W. R. Isolation, karyotype, and clonal growth of heterogeneous subpopulations of human malignant gliomas. Cancer Res., 41: 2349-2359, 1981.
16. Yamada, K., Kondo, T., Yoshioka, M., and Oami, H. Cytogenetic studies in twenty human brain tumors: association of no. 22 chromosome abnormalities with tumors of the brain. Cancer Genet. Cytogenet., 2: 293-307, 1980.
17. Bigner, S. H., Mark, J., and Bigner, D. D. Cytogenetics of human brain tumors. Cancer Genet. Cytogenet., 47: 141-154, 1990.
18. Rey, J. A., Bello, M. J., de Campos, J. M., Vaquero, J., Kusak, M. E., Sarasa, J. L., and Pestana, A. Abnormalities of chromosome 22 in human brain tumors determined by combined cytogenetic and molecular genetic approaches. Cancer Genet. Cytogenet., 66: 1-10, 1993.
19. Magnani, I., Guemeri, S., Pollo, B., Cirenei, N., Colombo, B. M., Broggi, G., Galli, C., Bugiana, O., DiDonato, S., Finocchiaro, G., and Conti, A. M. F. Increasing complexity of the karyotype in 50 human gliomas. Progressive evolution and de novo occurrence of cytogenetic alterations. Cancer Genet. Cytogenet., 75. 77-89, 1994.
20. Jenkins, R. B., Kimmel, D. W., Moertel, C A., Schultz, C. G., Scheithauer, B. W., Kelly, P. J., and Dewald, G. W. A cytogenetic study of 53 human gliomas. Cancer Genet. Cytogenet., 39: 253-279, 1989.
21. Arita, N., Hayakawa, T., Izumoto, S., Taki, T., Ohnishi, T., Yamamoto, H., Bitoh, S., and Mogami, H. Epidermal growth factor receptor in human glioma. J. Neurosurg., 70: 916-919, 1989.
22. Bruce, J. N., Duigou, G. J., and Fisher, P. B. Expression of the epidermal growth factor receptor in human central nervous system tumors. Cancer Cells, 7: 363-370, 1989.
23. Yamazaki, H., Fukui, Y., Ueyama, Y., Tamaoki, N., Kawamoto, T., Taniguchi, S., and Shibuya, M Amplification of the structurally and functionally altered epidermal growth factor receptor gene (c-erbB) in human brain tumors. Mol. Cell. Biol., 8: 1816-1820, 1988.
24. Wong, A. J., Ruppert, J M., Bigner, S. H., Grzeschik, C. H., Humphrey, P. A., Bigner, D. S., and Vogelstein, B. Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc. Natl. Acad. Sci. USA, 89: 2965-2969, 1992.
25. Ekstrand, A. J., Sugawa, N., James, C. D., and Collins, V. P. Amplified and rearranged EGFR genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails. Proc. Natl. Acad. Sci. USA, 89: 4309-4313, 1992.
26. Sugawa, N, Ekstrand, A. J., James, C. D., and Collins, V. P. Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastoma. Proc. Natl. Acad. Sci. USA, 87: 8602-8606, 1990.
27. Torp, S. H., Helseth, E., Ryan, L., Stolan, S., Dalen, A., and Unsgaard, G. Amplification of the epidermal growth factor receptor gene in human gliomas. Anticancer Res., 11: 2095-2098, 1991.
28. Torp, S. H., Heiseth, E., Dalen, A., and Unsgaard, G. Relationships between Ki-67 labelling index, amplification of the epidermal growth factor receptor gene, and prognosis in human glioblastoma. Acta Neurochir. (Wien)., 117: 182-186, 1992.
29. Schlegel, J., Merdes, A., Stumm, G., Albert, F. K., Forsting, M., Hynes, N., and Kiessling, M. Amplification of the epidermal-growth-factor-receptor gene correlates with different growth behavior in human glioblastoma. Int. J. Cancer, 56: 72-77, 1994.
30. Ekstrand, A. J., Longo, N., Hamid, M. L., Olson, J. J., Liu, L., Collins, V. P , and James, C. D. Functional characterization of an EGF receptor with a truncated extracellular domain expressed in GBMs with EGFR gene amplification. Oncogene. 9: 2313-2320, 1994.
31. Scheck, A. C., and Coons, S. W. Expression of the tumor suppressor gene DCC in human gliomas. Cancer Res., 53: 5605-5609, 1993.
32. Pertuiset, B., Dougherty, D, Cromeyer, C., Hoshino, T., Berger, M., and Rosenblum, M. L. Stem cell studies of human malignant brain tumors Part 2: Proliferation kinetics of brain-tumor cells in vitro in early-passage cultures. J. Neurosurg., 63: 426-432, 1985.
33. Zapryanov, Z., and Christov, K. Histological grading, DNA content, cell proliferation and survival of patients with astroglial tumors. Cytometry, 9: 380-386, 1988.
34. Coons, S. W , Johnson, P. C., and Pearl, D. K. Prognostic significance of flow cytometry deoxyribonucleic acid analysis in human astrocytomas. Neurosurgery, 35: 119-126, 1994.
35. Montine, T. J., Vandersteenhoven, J. J., Agussi, A., Boyko, O. B., Dodge, R. K., Kerns, B., and Burger, P. C. Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms. Neurosurgery, 34: 674-679, 1994.
36. Haapasalo, H., Isola, J., Sallinen, P., Kalimo, H., Helin, H., and Rantala, I. Aberrant p53 expression in astrocytic neoplasms of the brain: Association with proliferation. Am. J. Pathol., 142: 347-351, 1993.
37. He, J., Reifenberger, G., Liu, L, Collins, V. P., and James, C. D. Analysis of glioma cell lines for amplification and overexpression of MDM2. Genes Chromosomes & Cancer, 11: 91-96, 1994.
38. Louis, D. N. The p53 gene and protein in human brain tumors. J. Neuropathol Exp. Neurol., 53: 11-21, 1994.
39. Koga, H , Zhang, S., Kumanishi, T, Washiyama, K., Ichikawa, T., Tanaka, R., and Mukawa, J. Analysis of p53 gene mutations in low- and high-grade astrocytomas by polymerase chain reaction-assisted single-strand conformation polymorphism and immunohistochemistry. Acta Neuropathol., 87: 225-232, 1994.
40. Nistér, M., Wedwell, B., Betsholtz, C., Bywater, M., Pettersson, M., Westermark, B., and Mark, J. Evidence for progressional changes in the human malignant glioma line U-343 MGa: analysis of karyotype and expression of genes encoding the subunit chains of platelet-derived growth factor. Cancer Res., 47: 4953-4960, 1987.
41. Shapiro, J. R. Biology of gliomas: heterogeneity, oncogenes growth factors. Semin. Oncol., 8: 4-15, 1986.
42. Westermark, B., Nistér, M, and Heldin, C. Growth factors and oncogenes in human malignant glioma. Neurol. Clin., 3: 785-799, 1985.
43. Nistér, M., Libermann, T. A., Betsholtz, C., Pettersson, M., Classon-Welsh, L. Heldin, C., Schlessinger, J., and Westermark, B. Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-α and their receptors in human malignant glioma cell lines. Cancer Res., 48: 3910-3918, 1988.
44. Westphal, M., Brunken, M., Ronde, E., and Herrmann, H-D. Growth factors in cultured glioma cells. Cancer Lett., 38: 283-296, 1988.
45. Gillaspy, G. E., Mapstone, T. B., Samols, D., and Goldthwait, D. A. Transcriptional patterns of growth factors and proto-oncogenes in human glioblastomas and normal glial cells. Cancer Lett., 65: 55-60, 1992.
46. Burger, P. C., Scheithauer, B. W., and Vogel, F. S. Brain: tumors. Surgical Pathology of the Nervous System and Its Coverings, pp. 194-404. New York: Churchill Livingstone, 1991.
47. Kleihues, P., Burger, P. C., and Scheithauer, B. W. Histologic Typing of Tumours of the Central Nervous System. New York: Springer-Verlag, 1993.
48. Pieper, R. O., Futscher, B. W., Dong, Q., Ellis, T. M., and Erickson, L. C. Comparison of O-6-methylguanine DNA metnyltransferase (MGMT) mRNA levels in Mer-human tumor cell lines containing the MGMT gene by the polymerase chain reaction technique. Cancer Commun., 2: 13-20, 1990.
49. Scheck, A. C., Mehta, B. M., Beikman, M. K., and Shapiro, J. R. BCNU-resistant human glioma cells with over-representation of chromosomes 7 and 22 demonstrate increased copy number and expression of platelet-derived growth factor genes. Genes Chromosomes & Cancer, 8: 137-148, 1993.
50. Shapiro, J. R., Pu, P., Mohamed, A. N., Gahcich, J. H, Ebrahim, S. A. D., and Shapiro, W. R. Chromosome number and carmustine sensitivity in human gliomas. Cancer (Phila.), 71: 4007-4021, 1993.
51. Eisinger, M., Marko, O., Ogata, S., and Old, L. J. Growth regulation of human melanocytes: Mitogenic factors in extracts of melanoma, astrocytoma, and fibrofalast cell lines. Science (Washington DC). 229: 984-986, 1985.
52. Arbit, E., Malkin, M. G., Rosenblum, M., Anderson, L., Fiola, M. R., and Shapiro, J. R. Stereotactic implantation of high-activity iodine-125 seeds for the treatment of malignant glioma. Neurosurgery, 32: 105-110, 1993
53. An International System for Human Cytogenetic Nomenclature, p. 1. Basel S. Karger: [published in collaboration with Cytogenet. Cell Genet. (Suppl.)]. Karger, 1985.
54. Guidelines for cancer cytogenetics. Supplement to an International System for Human Genetic Nomenclature. New York: S. Karger, 1991.
55. Hedley, D. W., Friedlander, M. L., and Taylor, I. W. Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance. Cytometry, 6: 327-333, 1985.
56. Gerdes, J, Li, L., Schleuter, C., Duchrow, M., Wohlenberg, C., Gerlach, C., Stahmer, I., Kloth, S., Brandt, E., and Fiad, H. D. Immunobiochemical and molecular biological characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67 Am. J. Pathol., 138: 867-873, 1991.
57. Barnea, G., Grumet, M., Sap, J., Margolis, R. U., and Schlessinger, J. Close similarity between receptor-linked tyrosine phosphatase and rat brain proteoglycan. Cell, 76: 205, 1993.
58. Norman, S. A., Golfinos, J. G., and Scheck, A. C. Expression of a receptor protein tyrosme phosphatase (RPTPβ) in human malignant gliomas. Proc. Am. Assoc. Cancer Res., 36: 524, 1995.
59. Devilee, P., van Vliet, M., Kuipers-Dijkshoom, N., Pearson, P. L., and Cornelisse, C. J. Somatic genetic changes on chromosome 18 in breast carcinomas: is the DCC gene involved? Oncogene, 6: 311-315, 1991.
60. Neuman, W. L., Wasylyshyn, M. L., Jacoby, R., Erroi, F., Angriman, I., Montag, A., Brasitus, T., Michelassi, F., and Westbrook, C. A. Evidence for a common molecular pathogenesis in colorectal, gastric, and pancreatic cancer. Genes Chromosomes & Cancer, 3: 468-473, 1991.
61. Chenevix-Trench, G, Leary, J., Kerr, J., Michel, J., Kefford, R., Hurst, T., Parsons, P. G., Friedlander, M., and Khoo, S. K. Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus. Oncogene, 7: 1059-1065, 1992.
62. Gao, X., Honn, K. V., Grignon, D., Sakr, W., and Chen, Y. Q. Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas. Cancer Res., 53: 2723-2727, 1993.
63. Porfiri, E., Seeker-Walker, L. M., Hoffbrand, A. V., and Hancock, J. F. DCC tumor suppressor gene is inactivated in hematologic malignancies showing monosomy 18. Blood, 81: 2696-2701, 1993.
64. Ekstrand, B. C., Bigner, S. H., and Fearon, E. R. DCC gene mutations and loss of expression in glioblastomas. Proc. Am. Assoc. Cancer Res., 36: 574, 1995.
65. Davies, R. L., Grosse, V. A., Kucherlapati, R., and Bothwell, M. Genetic analysis of epidermal growth factor action: assignment of human epidermal growth factor receptor gene to chromosome 7. Proc. Natl. Acad. Sci. USA, 77: 4188-4192, 1980.
66. Kinzler, K. W., Bigner, S. H., Bigner, D. D., Trent, J. M., Law, M. L., O'Brien, S. J., Wong, A. J., and Vogelstein, B. Identification of an amplified, highly expressed gene in a human glioma. Science (Washington DC), 236: 70-73, 1987.
67. Bigner, S. H. Brain tumours: molecular aspects. Brain Pathol., 1: 11-18, 1990.
68. Libermann, T. A., Razon, N., Bartal, A. D., Yarden, Y., Schlessinger, J., and Soreq, H. Expression of epidermal growth factor receptors in human brain tumors. Cancer Res., 44: 753-760, 1984.
69. Ariyama, T., Hasegawa, H., Inazawa, J, Mizuno, K., Ogimoto, M., Katagiri, T., and Yakura, H. Assignment of the human protein tyrosine phosphatase, receptor-type, zeta (PTPRZ) gene to chromosome band 7q31.3. Cytogenet. Cell Genet., 70: 52-54, 1995.
70. Bigner, S. H., Mark, J., Mahaley, M. S., and Bigner, D. D. Patterns of the early, gross chromosomal changes in malignant human gliomas. Hereditas, 101: 103-113, 1984.
71. Bigner, S. H., Mark, J., Bullard, D. E., Mahaley, M. S. J., and Bigner, D. D. Chromosomal evolution in malignant human glioma starts with specific and usually numerical deviations. Cancer Genet. Cytogenet., 22: 121-135, 1986.
72. Thiel, G., Losanowa, T., Kintzel, D., Nisch, G., Martin, H., Vorpahl, K., and Witkowski, R. Karyotypes in 90 gliomas. Cancer Genet. Cytogenet., 58: 109-120, 1992.
73. Ransom, D. T., Ritland, S. R., Moertel, C. A., Dahl, R. J., O'Fallon, J. R., Scheithauer, B. W., Kimmel, D. W., Kelly, P. J., Olopade, O. I., Diaz, M. O., and Jenkins, R. B. Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligo-astrocytomas. Genes Chromosomes & Cancer, 5: 357-374, 1992.
74. Shapiro, J. R., Shapiro, W. R., Mohamed, A. N., and Pu, P. BCNU-sensitivity in parental cells and clones from four freshly resected near-diploid human gliomas: an astrocytoma, an anaplastic astrocytoma and two glioblastomas multiforme. J. Neuro-oncol., 15: 209-227, 1993.
75. Shapiro, J. R., and Shapiro, W. R. The subpopulations and isolated cell types of freshly resected high grade human gliomas: Their influence on the tumor's evolution in vivo and behavior and therapy in vitro. Cancer Metastasis Rev., 4: 107-124, 1985.
76. Shapiro, J. R. Cellular characterization and BCNU resistance of freshly resected and early passage human glioma cells. Prog. Neuropathol., 6: 133-143, 1986.
77. Rey, J. A., Bello, M. J., de Campos, J. M., Kusak, M. E., and Moreno, S. Chromosomal composition of a series of 22 human low-grade gliomas. Cancer Genet. Cytogenet., 29: 223-237, 1987.
78. Pruchon, E., Chauveinc, L., Sabatier, L., Dutrillaux, A. M., Ricoul, M., Delattre, J-Y., Vega, F., Poisson, M., Hor, F., and Dutrillaux, B. A cytogenetic study of 19 recurrent gliomas. Cancer Genet. Cytogenet., 76: 85-92, 1994.
79. Hoshino, T., Prados, M., Wilson, C. B., Cho, K. G, Lee, K.-S., and Davis, R. L. Prognostic implications of the bromodeoxyuridine labeling index of human gliomas. J. Neurosurg., 71, 335-341, 1989.
80. Wacker, M. R., Hoshino, T., Ann, D. K., Davis, R. L., and Prados, M. D. The prognostic implications of histologic classification and bromodeoxyuridine labeling index of mixed gliomas. J. Neuro-oncol., 19: 113-122, 1994.
81. Hoshino, T., Ahn, D., Prados, M. D., Lamborn, K., and Wilson, C. B. Prognostic significance of the proliferative potential of intracranial gliomas measured by bromodeoxyuridine labeling. Int. J. Cancer, 53: 550-555, 1993.
82. Coons, S W., Davis, J. W., and Way, D. L. Correlation of DNA content and histology in prognosis of astrocytomas. Am. J. Clin. Pathol., 90: 289-293, 1988.
83. Ito, S., Chandler, K. L., Prados, M. D., Lamborn, K., Wynne, J., Malec, M. K., Wilson, C. B, Davis, R. L., and Hoshino, T. Proliferative potential and prognostic evaluation of low-grade astrocytomas. J. Neuro-oncol., 19: 1-9, 1994.
84. Fearon, E. R., Cho, K. R., Nigro, J. M., Kern, S. E., Simons, J. W., Ruppert, J. M., Hamilton, S. R., Preisinger, A. C., Thomas, G., Kinzler, K. W., and Vogelstein, B. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science (Washington DC), 247:49-56, 1990.
85. Kreuger, N X, and Saito, H. Human transmembrane protein-tyrosine-phosphatase. PTPzeta, is expressed in brain and has an N-terminal receptor domain homologous to carbonic anhydrases. Proc. Natl. Acad. Sci. USA, 89: 7417-7421, 1992.